Predicting the risk of axillary nodal metastases and their use in selecting breast surgery options

Journal of Clinical Oncology

Volumn 27, Issue 34, 2009, Pages 5673-5675

  Jacobs, Lisa K ^a   Balch, Charles M ^a   Soong, Seng Jaw ^b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AXILLARY LYMPH NODE; BREAST CANCER; BREAST SURGERY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; EDITORIAL; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROGNOSIS; AXILLA; BREAST TUMOR; FEMALE; NOTE; PATHOLOGY; SENTINEL LYMPH NODE BIOPSY; STATISTICAL MODEL;

AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MODELS, STATISTICAL; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY;

EID: 73349114627     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2009.24.4525     Document Type: Editorial

References (25)

1. Lyman GH, Giuliano AE, Somerfield MR, et al: American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23:7703-7720, 2005
2. Karlsson P, Cole BF, Price KN, et al: The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer. J Clin Oncol 25:2019-2026, 2007
3. Jatoi I, Hilsenbeck SG, Clark GM, et al: Significance of axillary lymph node metastasis in primary breast cancer. J Clin Oncol 17:2334-2340, 1999
4. Kamath VJ, Giuliano R, Dauway EL, et al: Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: A study to evaluate the need for complete axillary lymph node dissection. Arch Surg 136:688-692, 2001
5. Colleoni M, Rotmensz N, Peruzzotti G, et al: Size of breast cancer metastases in axillary lymph nodes: Clinical relevance of minimal lymph node involvement. J Clin Oncol 23:1379-1389, 2005
6. Vanderveen KA, Schneider PD, Khatri VP, et al: Upstaging and improved survival of early breast cancer patients after implementation of sentinel node biopsy for axillary staging. Ann Surg Oncol 13:1450-1456, 2006
7. Cox CE, Kiluk JV, Riker AI, et al: Significance of sentinel lymph node micrometastases in human breast cancer. J Am Coll Surg 206:261-268, 2008
8. Park J, Fey JV, Naik AM, et al: A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram. Ann Surg 245:462-468, 2007
9. Hwang RF, Gonzalez-Angulo AM, Yi M, et al: Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection. Cancer 110:723-730, 2007
10. Werkoff G, Lambaudie E, Fondrinier E, et al: Prospective multicenter comparison of models to predict four or more involved axillary lymph nodes in patients with breast cancer with one to three metastatic sentinel lymph nodes. J Clin Oncol 27:5707-5712, 2009
11. Chagpar AB, Scoggins CR, Martin RC Jr, et al: Predicting patients at low probability of requiring postmastectomy radiation therapy. Ann Surg Oncol 14:670-677, 2007
12. Katz A, Smith BL, Golshan M, et al: Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer. J Clin Oncol 26:2093-2098, 2008
13. Llombart-Cussac A: Improving decision-making in early breast cancer: Who to treat and how? Breast Cancer Res Treat 112:15-24, 2008 (suppl 1)
14. Collins ED, Moore CP, Clay KF, et al: Can women with early-stage breast cancer make an informed decision for mastectomy? J Clin Oncol 27:519-525, 2009
15. Bevilacqua JL, Kattan MW, Fey JV, et al: Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation J Clin Oncol 25:3670-3679, 2007
16. Kohrt HE, Olshen RA, Bermas HR, et al: New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients. BMC Cancer 8:66, 2008
17. Scow JS, Degnim AC, Hoskin TL, et al: Assessment of the performance of the Stanford Online Calculator for the prediction of nonsentinel lymph node metastasis in sentinel lymph node-positive breast cancer patients. Cancer 115:4064-4070, 2009
18. Van Zee KJ, Manasseh DM, Bevilacqua JL, et al: A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 10:1140-1151, 2003
19. van la Parra RF, Ernst MF, Bevilacqua JL, et al: Validation of a nomogram to predict the risk of nonsentinel lymph node metastases in breast cancer patients with a positive sentinel node biopsy: Validation of the MSKCC breast nomogram. Ann Surg Oncol 16:1128-1135, 2009
20. Gur AS, Unal B, Johnson R, et al: Predictive probability of four different breast cancer nomograms for nonsentinel axillary lymph node metastasis in positive sentinel node biopsy. J Am Coll Surg 208:229-235, 2009
21. Houvenaeghel G, Nos C, Giard S, et al: A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis. Eur J Surg Oncol 35:690-695, 2009
22. Jain A, Haisfield-Wolfe ME, Lange J, et al: The role of ultrasound-guided fine-needle aspiration of axillary nodes in the staging of breast cancer. Ann Surg Oncol 15:462-471, 2008
23. Lovrics PJ, Chen V, Coates G, et al: A prospective evaluation of positron emission tomography scanning, sentinel lymph node biopsy, and standard axillary dissection for axillary staging in patients with early stage breast cancer. Ann Surg Oncol 11:846-853, 2004
24. Kronowitz SJ, Kuerer HM: Advances and surgical decision-making for breast reconstruction. Cancer 107:893-907, 2006
25. Kronowitz SJ, Hunt KK, Kuerer HM, et al: Delayed-immediate breast reconstruction. Plast Reconstr Surg 113:1617-1628, 2004